Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus
- PMID: 11026555
- DOI: 10.1016/s0303-7207(00)00236-7
Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus
Abstract
Vasopressin V2 receptor mutants from three different patients with congenital nephrogenic diabetes insipidus phenotypes were investigated after expression in COS cells. The amino acid exchanges within the human V2 receptor are located in the second extracellular loop (T204N, Y205C and V206D). Confocal microscopy showed that all receptor mutants were strongly expressed but mainly located within the cell. Residual binding capacity for the antidiuretic hormone arginine vasopressin (AVP) could only be detected for the T204N mutant and was 10-fold lower than for the wild-type receptor. Stimulation of transfected cells with 1 microM AVP showed that the T204N mutant was able to activate the adenylyl cyclase pathway. In contrast, the Y205C mutant was almost inactive and stimulation of the V206D mutant increased the cAMP accumulation only slightly. Dose dependent stimulation of cells expressing the T204N mutant with AVP and with the therapeutic AVP analogue 1-deamino[D-Arg8]vasopressin (dDAVP) revealed that AVP was 50-fold more potent than dDAVP. This indicates that the ligand binding selectivity of the T204N mutant has changed as compared with the wild-type receptor where AVP is only 2.3-fold more potent than dDAVP. Despite its defects in membrane localization, ligand binding affinity and selectivity, the T204N receptor could be activated with high concentrations of dDAVP. Our results indicate that in cases of congenital nephrogenic diabetes insipidus with residual V2 receptor activities the use of antidiuretic drugs, such as dDAVP, might be beneficial for patients.
Similar articles
-
An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.Mol Endocrinol. 1994 Jul;8(7):886-94. doi: 10.1210/mend.8.7.7984150. Mol Endocrinol. 1994. PMID: 7984150
-
The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.J Clin Endocrinol Metab. 2001 Jan;86(1):381-5. doi: 10.1210/jcem.86.1.7165. J Clin Endocrinol Metab. 2001. PMID: 11232028
-
Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.Am J Physiol Renal Physiol. 2005 Aug;289(2):F265-72. doi: 10.1152/ajprenal.00404.2004. Am J Physiol Renal Physiol. 2005. PMID: 16006591
-
Vasopressin receptor mutations causing nephrogenic diabetes insipidus.Proc Assoc Am Physicians. 1998 Sep-Oct;110(5):387-94. Proc Assoc Am Physicians. 1998. PMID: 9756088 Review.
-
Nephrogenic diabetes insipidus.Am J Med. 1998 Nov;105(5):431-42. doi: 10.1016/s0002-9343(98)00301-5. Am J Med. 1998. PMID: 9831428 Review.
Cited by
-
Exploring the diversity of AVPR2 in Primates and its evolutionary implications.Genet Mol Biol. 2023 Nov 3;46(3):e20230045. doi: 10.1590/1678-4685-GMB-2023-0045. eCollection 2023. Genet Mol Biol. 2023. PMID: 37930141 Free PMC article.
-
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.Sci Signal. 2020 Feb 4;13(617):eaaw5885. doi: 10.1126/scisignal.aaw5885. Sci Signal. 2020. PMID: 32019899 Free PMC article.
-
Study of V2 vasopressin receptor hormone binding site using in silico methods.Res Pharm Sci. 2015 Jul-Aug;10(4):288-94. Res Pharm Sci. 2015. PMID: 26600856 Free PMC article.
-
Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report.Clin Pediatr Endocrinol. 2022;31(2):87-92. doi: 10.1297/cpe.2021-0032. Epub 2022 Feb 18. Clin Pediatr Endocrinol. 2022. PMID: 35431445 Free PMC article.
-
A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.Pediatr Nephrol. 2007 May;22(5):670-3. doi: 10.1007/s00467-006-0388-8. Epub 2007 Jan 10. Pediatr Nephrol. 2007. PMID: 17216256
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous